Expression and significance of tumor infiltrating dendritic cells in renal cell carcinoma

Chinese Journal of Cancer Research

Volumn 17, Issue 2, 2005, Pages 127-131

  Feng, Jian Wei ^a,b   Chen, Yi Rong ^b   Shi, Bao Guang ^b   Yan, Dong Wen ^b   Wagn, Jin Sui ^b  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

Author keywords

Dendritic cell; Renal cell carcinoma; Transforming growing factor 1; Tumor infiltrating dendritic cell; Vascular endothelial growth factor

Indexed keywords

CD38 ANTIGEN; CD83 ANTIGEN; CYTOKINE; PEROXIDASE; STREPTAVIDIN; T6 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MALE; STATISTICAL SIGNIFICANCE; TUMOR INFILTRATING DENDRITIC CELL;

EID: 21444435553     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-005-0057-7     Document Type: Article

References (20)

1. Chaux P, Hammann A, Martin A, et al. Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation[J]. Eur J Immunol 1993; 23: 2517-25.
2. Iwamoto M, Shinohara H, Miyamoto A, et al. Prognostic value of tumor-infiltrating dendritic cells expression CD83 in human breast carcinoma[J]. Int J Cancer 2003; 104: 92-7.
3. Cella M, Sallusto F, Landzavecchia A. Origin, maturation and antigen presenting function of dendritic cells[J]. Curr Opin Immunol 1997; 9: 10-6.
4. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response[J]. Blood 1997; 90: 3245-87.
5. Banchereau J, Steinman RM. Dendritic cells and control of immunity[J]. Nature 1998; 392: 245-52.
6. Chaux P, Favre N, Martin M, et al. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats[J]. Int J Cancer 1997; 72: 619-24.
7. Chaux P, Moutet M, Faivre J, et al. Inflammatory cells infiltrating human colorectal carcinoma expression HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation[J]. Lab Invest 1996; 74: 975-83.
8. Thurnher M, Radmayr C, Ramoner R, et al. Human renal-cell carcinoma tissue contains dendritic cells[J]. Int J Cancer 1996; 68: 1-7.
9. Troy AJ, Summera KL, Davidson PJ, et al. Minimal recruitment and activation of dendritic cells within renal cell carcinoma[J]. Clin Cancer Res 1998; 4: 585-93.
10. Ishigami S, Aikou T, Natsugoe S, et al. Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer[J]. Oncology 1998; 55: 65-9.
11. Maehara Y, Kabashima A, Tokunaga E, et al. Tumor-infiltrating dendritic cells in adenocarcinoma of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome[J]. Int J Cancer 1999; 56: 322-7.
12. Lespagnard L, Gancberg D, Rouas G, et al. Tumor-infiltrating dendritic cells in adenocarcinoma of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome[J]. Int J Cancer 1999; 84: 309-14.
13. Takahashi K, Isobe T, Ohtsuki Y, et al. Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues[J]. Virchows Arch B Cell Pathol Incl Mol Pathol 1984; 45: 385-96.
14. Bell D, Chomarat P, Broyles D, et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are locate in peritumoral areas[J]. J Exp Med 1999; 190: 1417-25.
15. Schwaab T, Schned AR, Heaney JA, et al. In vivo description of dendritic cells in human renal cell carcinoma[J]. J Urol 1999; 162: 567-73.
16. Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily[J]. J Immunol 1995; 154: 3821-35.
17. Gabrilovich DI, Ishida T, Nadaf S, et al. Antibodies to vascular endothelial growth enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function[J]. Clin Cancer Res 1999; 5: 2963-70.
18. Gabrilvovich DI, Chen HL, Girgis KR, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells[J]. Nat Med 1996; 2: 1096-103.
19. Allavena P, Piemonti L, Longoni D, et al. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages[J]. Eur J Immunol 1998; 28: 359-369.
20. D'orazio TJ, Niederkom J Y. A novel role for TGF-β and IL-10 in the induction of immune privilege[J]. J Immunol 1998; 160: 2089-98.